Mankind Pharma Ltd. - Research Center
543904 MANKIND Group (B) BSE data
Results
|
Quarterly
|
Statement
|
|
More
|
|
Quarterly results in brief
(Rs crore)
|
Mar' 24 |
Dec' 23 |
Sep' 23 |
Jun' 23 |
Mar' 23 |
Sales |
2,152.69 |
2,358.57 |
2,453.35 |
2,300.21 |
1,872.12 |
Operating profit |
547.33 |
603.11 |
635.19 |
539.47 |
381.16 |
Interest |
4.03 |
4.26 |
4.31 |
1.97 |
0.88 |
Gross profit |
627.15 |
666.08 |
689.00 |
594.94 |
422.73 |
EPS (Rs) |
11.34 |
12.16 |
11.80 |
10.22 |
7.01 |
Quarterly
results in details
|
Mar' 24 |
Dec' 23 |
Sep' 23 |
Jun' 23 |
Mar' 23 |
Other income |
83.85 |
67.23 |
58.12 |
57.44 |
42.46 |
Stock adjustment |
-67.33 |
24.14 |
-2.08 |
19.91 |
21.00 |
Raw material |
213.15 |
205.21 |
229.96 |
213.41 |
163.93 |
Power and fuel |
- |
- |
- |
- |
- |
Employee expenses |
507.93 |
492.68 |
500.29 |
481.20 |
431.07 |
Excise |
- |
- |
- |
- |
- |
Admin and selling expenses |
- |
- |
- |
- |
- |
Research and development expenses |
- |
- |
- |
- |
- |
Expenses capitalised |
- |
- |
- |
- |
- |
Other expenses |
951.60 |
1,033.43 |
1,089.98 |
1,046.22 |
874.96 |
Provisions made |
- |
- |
- |
- |
- |
Depreciation |
82.29 |
89.73 |
77.04 |
68.54 |
67.30 |
Taxation |
90.69 |
89.28 |
139.08 |
117.11 |
74.45 |
Net profit / loss |
454.17 |
487.07 |
472.88 |
409.28 |
280.99 |
Extra ordinary item |
- |
- |
- |
- |
- |
Prior year adjustments |
- |
- |
- |
- |
- |
Equity capital |
40.06 |
40.06 |
40.06 |
40.06 |
40.06 |
Equity dividend rate |
- |
- |
- |
- |
- |
Agg.of non-prom. shares (Lacs) |
- |
- |
- |
- |
- |
Agg.of non promotoholding (%) |
- |
- |
- |
- |
- |
OPM (%) |
25.43 |
25.57 |
25.89 |
23.45 |
20.36 |
GPM (%) |
28.04 |
27.46 |
27.43 |
25.23 |
22.08 |
NPM (%) |
20.31 |
20.08 |
18.83 |
17.36 |
14.68 |